Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Development of a Real Time Pharmacokinetic Testing Method to Allow for Targeted Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Transplant

Karen Sweiss, PharmD, Bhaskar Vemu, PhD, Gregory Sampang Calip, PharmD,MPH,PhD, John P Galvin, MDMS,MPH, John G. Quigley, Nadim Mahmud, MBBS, PhD, Damiano Rondelli, MD, Jeremy Johnson, PharmD, PhD, Pritesh Patel, MB, ChB

Blood (2019) 134 (Supplement_1): 3310.

https://doi.org/10.1182/blood-2019-132216

Published: 2019

Journal Articles

Cryo-EM Structure of BIVV001 Reveals Coagulation Factor VIII-Von Willebrand Factor D'D3 Interaction Mode

James Fuller, PhD, Joseph Batchelor, PhD, Kevin Knockenhauer, PhD, Hans-Peter Biemann, PhD, Robert Peters

Blood (2019) 134 (Supplement_1): 94.

https://doi.org/10.1182/blood-2019-126645

Published: 2019

Journal Articles

Desideromastica: Tactile Chew Cravings in Iron Deficiency Anemia

Caleb J Scheckel, DO, Didar Yanardag Acik, MD, Aneel A. Ashrani, MD MS, C. Christopher Hook, MD, Lindsey Ann Kluck, APRN, CNP, MSN, Ariela L. Marshall, MD, Rajiv K. Pruthi, MBBS, Aishwarya Ravindran, MBBS, Mithun Vinod Shah, MD PhD, Alexandra Wolanskyj, MD, Ronald S. Go, MD

Blood (2019) 134 (Supplement_1): 4815.

https://doi.org/10.1182/blood-2019-127306

Published: 2019

Journal Articles

Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation "MSC-FFM": Treatment Results for 92 Consecutive Patients

Blood (2018) 132 (Supplement 1): 603.

https://doi.org/10.1182/blood-2018-99-110599

Published: 2018

Journal Articles

A Standardized Kit for a Chromogenic Modified Nijmegen-Bethesda Assay: Repeatability, Reproducibility, and Analytical Sensitivity

Colin Douglas, PhD, Tara Quinton, MSc, Ellinore Cabanban, BSc, Karen Black, PhD, Ali Sadeghi-Khomami, PhD

Blood (2018) 132 (Supplement 1): 1201.

https://doi.org/10.1182/blood-2018-99-119491

Published: 2018

Journal Articles

Comparison of Frontline Induction Therapy Using Idarubicin in Combination with High-Dose (HDAC3) Versus Intermediate-Dose Cytarabine (IDAC3) in Adult Acute Myeloid Leukemia

Ing Soo S Tiong, MBBS, Katherine Fielding, MBBS, BMedSci, Chun Y Fong, MBBS, BMedSci, FRACP,FRCPA, Hadley Bortz, BPharm, GradCert PharmPrac, MClinPharm, MSHP, Sharon Avery, MBBS, FRACP, FRCPA, Andrew P Grigg, MBBS, MD FRACP, FRCPA, Andrew Wei, MBBS, PhD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 3868.

https://doi.org/10.1182/blood.V130.Suppl_1.3868.3868

Published: 2017

Journal Articles

Reducing Gastrointestinal Toxicity Associated with Autologous Transplantation for Multiple Myeloma without Compromising Its Anti-Myeloma Effect

Ehsan Malek, MD, Richard Creger, PhD, Merle Kolk, Fahrettin Covut, MD, Richard E Champlin, MD, Brenda W. Cooper, MD, Paolo Caimi, MD, Hillard M Lazarus, MD, Vinita Gupta, MD, Anant Vatsayan, MD MBBS, Qaiser Bashir, MD MBBS, Marcos De Lima, MD, Muzaffar H. Qazilbash, MD

Blood (2017) 130 (Supplement 1): 680.

https://doi.org/10.1182/blood.V130.Suppl_1.680.680

Published: 2017

Journal Articles

Skating on Thin Ice: National Audit of TACO Demonstrates Poor Recognition of Risk Factors

Suzy Morton, FRCPath, MRCP, MBBS, John Grant-Casey, Paula Bolton-Maggs, DM, FRCP, FRCPath, Urmila Tandon, MBChB, MRCP, Jayne Addison, Anna Bartholomew, Lise Estcourt, DPhil, FRCPath, MBBChir, MRCP, MSc, MA

Blood (2017) 130 (Supplement 1): 2406.

https://doi.org/10.1182/blood.V130.Suppl_1.2406.2406

Published: 2017

Journal Articles

Prevalence and Prognostic Impact of FLT3-ITD and NPM1 Mutations: A Cohort of Patients with Acute Myeloid Leukemia from the ABC-SP, Brazil

Carolina Susanna, MS, José Henrique Borducchi, MS, Vitor Mauad, MD, Adriana Del Giglio, MD, Itatiana Rodart, PhD, Auro Del Giglio, PhD, Davimar Miranda Maciel Borducchi, PhD

Blood (2017) 130 (Supplement 1): 5095.

https://doi.org/10.1182/blood.V130.Suppl_1.5095.5095

Published: 2017

Journal Articles

New Cooling Device for Oral Mucosa Better Tolerated and Equally Effective As Ice Cooling

Java Walladbegi, DDS, PhDStudent, Anncarin Svanberg, RN, PhD, Gunnar Birgegard, MD PhD, Mats Jontell, DDS, PhD Prof.

Blood (2016) 128 (22): 5806.

https://doi.org/10.1182/blood.V128.22.5806.5806

Published: 2016

Journal Articles

Autologous Hematopoietic Progenitor Cell Infusion Adverse Event Associated with Apheresis Product Granulocyte Content

Araci M. Sakashita, MD, Andrea Tiemi Kondo, MD, Ana Paula Hitomi Yokoyama, MD, Carolina Bonet Bub, MD, Sanny Marcele da Costa Lira, MD, Cristiane Yoshie Nakazawa, MD, Andrea Neri Folchini Cipolletta, RN, Nelson Hamerschlak, PhD, Jose M Kutner, MD PhD

Blood (2015) 126 (23): 4308.

https://doi.org/10.1182/blood.V126.23.4308.4308

Published: 2015

Journal Articles

Evaluation of Pharmacokinetic-Based Dose Predictions of High Dose Melphalan in Patients with Myeloma

Judith Trotman, MBChB, Peter J. Shaw, MBBS, MA, FRACP, Campbell Tiley, MBBS,FRACP, FRCPA, Sundra Ramanathan, MBBS FRCPA FRACP, Andrew P Grigg, MBBS MD, Stephen Robert Larsen, MBBS PhDFRCPA FRACP, Peter Presgrave, MBBS, PhD FRACP, FRCPA, Yiu-Lam Kwan, MBBS, FRACP, FRCPA, Elizabeth Newman, RN, Christa Nath, BSC (Hons), PhD

Blood (2015) 126 (23): 4314.

https://doi.org/10.1182/blood.V126.23.4314.4314

Published: 2015

Journal Articles

Amifostine Reduces High-Dose Melphalan Induced Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplant (HCT) for Plasma Cell Myeloma

Vinita Gupta, MD, Hulya Armutlugoynuk, MD, Anant Vatsayan, MD MBBS, Paolo F. Caimi, MD, Brenda Cooper, MD, Leland Metheny, MD, Ehsan Malek, MD, Erica L. Campagnaro, MD, Stan Gerson, MD, Marcos de Lima, MD, Hillard M. Lazarus, MD, Richard J Creger, PharmD

Blood (2015) 126 (23): 5491.

https://doi.org/10.1182/blood.V126.23.5491.5491

Published: 2015

Journal Articles

Hemogenic Endothelium-like Changes Were Derived to an Adult Human Dermal Fibroblast By Electrical Stimulation

Takuji Matsuo, MD, Ryosuke Shirasaki, MD PhD, Oka Yoko, MD, PhD, Tadashi Yamamoto, MD, Jun Ooi, MD, Kennsuke Matsumoto, MD, PhD, Naoki Shirafuji, MDPhD

Blood (2014) 124 (21): 5129.

https://doi.org/10.1182/blood.V124.21.5129.5129

Published: 2014

Journal Articles

Maintenance Lenalidomide for Adults Aged 18-65 Years with AML in First Complete Remission after Intensive Chemotherapy: A Phase Ib Dose-Escalation Study of the Australasian Leukemia and Lymphoma Group (ALLG)

Andrew Wei, MBBS, PhD, Ian D Lewis, MBBS, PhD, Uwe Hahn, MD, Gavin Cull, MBBS, DM, FRACP, FRCPA, Anoop Enjeti, MBBS, MD FRCPA, Philip Campbell, MBBS, FRACP, FRCPA, Simon Z. He, MBBS,FRACP,FRCPA, Mark S Hertzberg, MBBS PhDFRACP FRCPA, John F Seymour, MBBS, FRACP, PhD

Blood (2014) 124 (21): 944.

https://doi.org/10.1182/blood.V124.21.944.944

Published: 2014

Journal Articles

Sample Processing Obscures Cancer-Specific Alterations in Leukemic Transcriptomes

Heidi Dvinge, PhD, Rhonda E. Ries, MA, Janine O. Ilagan, PhD, Derek L. Stirewalt, MD, Soheil Meshinchi, MD PhD, Robert K. Bradley, PhD

Blood (2014) 124 (21): 2201.

https://doi.org/10.1182/blood.V124.21.2201.2201

Published: 2014

Journal Articles

2-Hour Cryotherapy Effectively Reduces Severe Mucositis Associated with High-Dose Melphalan Followed By Stem Cell Rescue: Results from a Randomized Trial

Douglas W. Sborov, MD, Misty Lamprecht, CNS, Don Benson, MD PhD, Karen Tackett, RN, Yvonne A Efebera, MD, Rosko E Ashley, MD, Steven M. Devine, MD, Ming Poi, PharmD, PhD, Mitch A. Phelps, PhD, Craig C Hofmeister, MD MPH

Blood (2014) 124 (21): 3960.

https://doi.org/10.1182/blood.V124.21.3960.3960

Published: 2014

Journal Articles

High Dose Cytarabine (HiDAC) and Fludarabine Without Anthracycline For Patients With Core Binding Factor (CBF) Acute Myeloid Leukemia (AML): The Australasian Leukaemia and Lymphoma Group (ALLG) AMLM13 Study

Paula Marlton, MBBS, John F Seymour, MBBS, PhD, Kenneth Bradstock, MBBS, PhD, Ian D Lewis, MB, BS, PhD, Russell Saal, BAppSci, MMedSci, Lyle McMillen, BSc, PhD, Juliana Di Iulio, BAppSc, PhD, Diana Zannino, BSc, MSc, Andrew Grigg, MBBS

Blood (2013) 122 (21): 1444.

https://doi.org/10.1182/blood.V122.21.1444.1444

Published: 2013

Journal Articles

In Vitro Production Of Megakaryocytes and Platelets From Human Induced Pluripotent Cells By GMP Compatible Methods

Thomas Moreau, PhD, Maria Colzani, Meera Arumugam, PhD, Amanda Evans, Marloes Renee Tijssen, PhD, Matthew Trotter, PhD, Willem H Ouwehand, Roger Pedersen, MD PhD, Cedric Ghevaert, MD PhD

Blood (2013) 122 (21): 2401.

https://doi.org/10.1182/blood.V122.21.2401.2401

Published: 2013

Journal Articles

Single-Cell Pharmacodynamic Monitoring of Ribosomal Protein S6 Phosphorylation During AC220 Therapy Demonstrates in Vivo FLT3 Inhibition in Circulating Leukemic Blasts and Accurately Detects the Development of AC220 Resistance.

Alexander E Perl, MD, Grace R Jeschke, Catherine C Smith, MD, James K. Mangan, MD, PhD, Selina M. Luger, MD, Martin Carroll, MD

Blood (2012) 120 (21): 2453.

https://doi.org/10.1182/blood.V120.21.2453.2453

Published: 2012

NARROW

Development of a Real Time Pharmacokinetic Testing Method to Allow for Targeted Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Transplant

Cryo-EM Structure of BIVV001 Reveals Coagulation Factor VIII-Von Willebrand Factor D'D3 Interaction Mode

Desideromastica: Tactile Chew Cravings in Iron Deficiency Anemia

Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation "MSC-FFM": Treatment Results for 92 Consecutive Patients

A Standardized Kit for a Chromogenic Modified Nijmegen-Bethesda Assay: Repeatability, Reproducibility, and Analytical Sensitivity

Comparison of Frontline Induction Therapy Using Idarubicin in Combination with High-Dose (HDAC3) Versus Intermediate-Dose Cytarabine (IDAC3) in Adult Acute Myeloid Leukemia

Reducing Gastrointestinal Toxicity Associated with Autologous Transplantation for Multiple Myeloma without Compromising Its Anti-Myeloma Effect

Skating on Thin Ice: National Audit of TACO Demonstrates Poor Recognition of Risk Factors

Prevalence and Prognostic Impact of FLT3-ITD and NPM1 Mutations: A Cohort of Patients with Acute Myeloid Leukemia from the ABC-SP, Brazil

New Cooling Device for Oral Mucosa Better Tolerated and Equally Effective As Ice Cooling

Autologous Hematopoietic Progenitor Cell Infusion Adverse Event Associated with Apheresis Product Granulocyte Content

Evaluation of Pharmacokinetic-Based Dose Predictions of High Dose Melphalan in Patients with Myeloma

Amifostine Reduces High-Dose Melphalan Induced Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplant (HCT) for Plasma Cell Myeloma

Hemogenic Endothelium-like Changes Were Derived to an Adult Human Dermal Fibroblast By Electrical Stimulation

Maintenance Lenalidomide for Adults Aged 18-65 Years with AML in First Complete Remission after Intensive Chemotherapy: A Phase Ib Dose-Escalation Study of the Australasian Leukemia and Lymphoma Group (ALLG)

Sample Processing Obscures Cancer-Specific Alterations in Leukemic Transcriptomes

2-Hour Cryotherapy Effectively Reduces Severe Mucositis Associated with High-Dose Melphalan Followed By Stem Cell Rescue: Results from a Randomized Trial

High Dose Cytarabine (HiDAC) and Fludarabine Without Anthracycline For Patients With Core Binding Factor (CBF) Acute Myeloid Leukemia (AML): The Australasian Leukaemia and Lymphoma Group (ALLG) AMLM13 Study

In Vitro Production Of Megakaryocytes and Platelets From Human Induced Pluripotent Cells By GMP Compatible Methods

Single-Cell Pharmacodynamic Monitoring of Ribosomal Protein S6 Phosphorylation During AC220 Therapy Demonstrates in Vivo FLT3 Inhibition in Circulating Leukemic Blasts and Accurately Detects the Development of AC220 Resistance.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only